The fragile antibiotic market has reached a tipping point

At the Access to Medicine Foundation, we have been analysing how pharmaceutical companies tackle access to medicine for more than a decade. This 2020 Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.

Explore further

Back to top |